CENTERS for Disease Control & Prevention (U.S.)OLDER peopleRESPIRATORY syncytial virus infection vaccinesAUTUMNThe article reports on the revised respiratory syncytial virus (RSV) vaccination recommendation from the U.S. Centers for Disease Control and PRecention (CDC) for people age...
Originally, Arexvy was the only FDA-approved RSV vaccine for older adults. However, since this approval, two other RSV vaccines have come to market. The Pfizer RSV vaccine, Abrysvo, is also a protein subunit vaccine. The CDC estimates the effectiveness of protein subunit RS...
The U.S. Food and Drug Administration on Tuesday approvedPfizer's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of the disease. In June, the U.S. CDCnarrowedits recommendation for the use of respiratory ...
The researchers in this latest study reported that effectiveness was similar for both shots. The CDC currently recommends that everyone ages 75 and older get at least one dose, and adults ages 60 to 74 should get a dose if they have a higher risk of severe RSV, such as having chronic ...
Adults who are at the highest risk for severe illness from RSV include adults with chronic heart or lung disease, adults with weakened immune systems, older adults, and adults living in nursing homes or long-term care facilities, according to the statement. The CDC estimates that RSV causes ap...
The first vaccines to guard against therespiratory illness RSVwill soon be available for some older adults, ages 60 and over, after the CDC formally backed recommendations for the shots. The move, announced Thursday, followed a vote at ameetingof the CDC's Advisory Committee on Immunization Prac...
在2024 年 6 月的会议上,CDC 免疫实践咨询委员会 (ACIP) 投票决定更新老年人 RSV 疫苗接种建议:所有 75 岁或以上的成年人以及 60 至 74 岁的成年人,如果患严重 RSV 的风险较高,应接种一剂 RSV 疫苗。在 2023 年 9 月的 ACIP 会议上,Abrysvo 被推荐用于孕产妇免疫。
关于“Arexvy”接种频率等具体问题，这将由美国疾病控制与预防中心（CDC）的免疫咨询委员会决定。路透社称，一位CDC发言人表示，委员会将在6月末举行会议，届时将讨论GSK的RSV疫苗接种相关话题。预计销售额峰值达25亿美元 此前，GSK一直与美国辉瑞（Pfizer）公司并驾齐驱进行RSV疫苗的开发，并相继获得FDA优先审评权。
在2024 年 6 月的会议上,CDC 免疫实践咨询委员会 (ACIP) 投票决定更新老年人 RSV 疫苗接种建议:所有 75 岁或以上的成年人以及 60 至 74 岁的成年人,如果患严重 RSV 的风险较高,应接种一剂 RSV 疫苗。在 2023 年 9 月的 ACIP 会议上,Abrysvo 被推荐用于孕产妇免疫。数据显示,MONET 研究达到了其共同...
CDC. Health care providers: RSV vaccination for adults 60 years of age and over.https://www.cdc.gov/vaccines/vpd/rsv/hcp/older-adults.html. Last reviewed March 1, 2024. Accessed June 26, 2024.